Literature DB >> 3373549

Improved survival of patients with cancers of the colon and rectum?

P Enblad1, H O Adami, R Bergström, B Glimelius, U Krusemo, L Påhlman.   

Abstract

The survival of 61,769 patients diagnosed as having colorectal cancer in the total Swedish population in 1960-1981 was analyzed. The 5-year relative survival rates during the total period were approximately 40%; patients with colonic carcinoma had a somewhat better prognosis than patients with rectal carcinoma, and men had a generally less favorable prognosis than women. Comparison of patients diagnosed in 1960-1964 and in 1975-1979 showed a slight improvement in survival during the more recent study period, i.e., an improvement rate of 7.0% for both cancer of the colon and cancer of the rectum. The improvement occurred mainly during the first months of follow-up. However, the excess mortality due to colorectal cancer 1-5 years after diagnosis as compared to the expected mortality in the general population remained virtually unaltered. A multivariate analysis in which adjustment was made for the possible confounding variables of sex, age, and site (of colonic carcinoma) gave consistent results. Reduced postoperative mortality was considered to be the most likely major explanation for the temporal trend toward a more favorable prognosis. Thus it seemed that the treatment of colorectal cancer in Sweden during the last two decades has not improved significantly except in terms of reduced postoperative mortality. Thus the challenge of improving survival in patients with colorectal cancer must be given high priority.

Entities:  

Mesh:

Year:  1988        PMID: 3373549     DOI: 10.1093/jnci/80.8.586

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  What is progress against cancer?

Authors:  H O Adami
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

2.  Survival after colon cancer 1973-1990 in Sweden. Convergence between catchment areas.

Authors:  P Blomqvist; A Ekbom; O Nyrén; U Krusemo; R Bergström; H O Adami
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

3.  Prognosis in familial non-polyposis colorectal cancer.

Authors:  F Kee; B J Collins; C C Patterson
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

4.  Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer.

Authors:  Lei Chen; Beihai Jiang; Zaozao Wang; Maoxing Liu; Yiyuan Ma; Hong Yang; Jiadi Xing; Chenghai Zhang; Zhendan Yao; Nan Zhang; Ming Cui; Xiangqian Su
Journal:  Med Oncol       Date:  2013-02-20       Impact factor: 3.064

5.  Prognostic significance of p53-expression in colorectal carcinoma as measured by a luminometric immunoassay.

Authors:  Oliver Lotter; Amro Amr; Farouk Safi
Journal:  Ger Med Sci       Date:  2010-10-08

Review 6.  Colorectal cancer, one entity or three.

Authors:  Feng-ying Li; Mao-de Lai
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

7.  Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group.

Authors:  K Kakudo; W Tang; Y Ito; I Mori; Y Nakamura; A Miyauchi
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

8.  Colon cancer in France: evidence for improvement in management and survival.

Authors:  C Faivre-Finn; A-M Bouvier-Benhamiche; J M Phelip; S Manfredi; V Dancourt; J Faivre
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 9.  Primary therapy of carcinoma of the large bowel.

Authors:  V W Fazio; J J Tjandra
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

10.  Preoperative prediction of late cancer-specific deaths in patients with rectal and rectosigmoid carcinoma.

Authors:  E Ståhle; B Glimelius; R Bergström; L Påhlman
Journal:  Int J Colorectal Dis       Date:  1989-08       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.